Track PAVmed- Warrants (29/01/2022)'s receivables ($16K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), PAVMW shows a receivables of $16K. That compares with $3M in the prior-year period — down 99.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, PAVMW's receivables is now $16K (was $3M) — a 99.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether PAVmed- Warrants (29/01/2022) is outperforming or lagging.
Tracking PAVMW's receivables over time shows whether PAVmed- Warrants (29/01/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $16K That compares with $3M in the prior-year period — down 99.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has PAVmed- Warrants (29/01/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $16K) with ownership activity and broader fundamentals.
PAVmed- Warrants (29/01/2022)'s receivables is $16K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.